MADISON (WKOW) -- Abbott announced it will acquire Exact Sciences for an approximate enterprise value of $23 billion.
Exact Sciences, a Madison-based company, is known for several products that focus on early cancer detection.
The sale is expected to close in the second quarter of 2026 and is still subject to approvals and other conditions.
According to a press release, Exact Sciences will keep its presence in Madison after the closing.
In the press release, Kevin Conroy, chairman and chief executive officer of Exact Science, thanked Exact Sciences' team members and said the 'journey has just begun.'
More at WKOW 27 News